Our results identify new metabolic pathways deregulated in primary MYC tumors and implicate a role for MYC in regulating a major antioxidant pathway downstream of glutamine
However, metformin is oral, inexpensive, and has an extensive safety record, making it the preferred initial therapy
So, if tirzepatide can do that to COCs, what might it do to oral progestogens like utrogestan
For someone with metabolic syndrome who jumps on a GLP-1 and drinks heavily every weekend, thats a different risk profile than someone with well-controlled diabetes, normal lipids, and no alcohol use, Perez said
Despite the presence of off-patent alternatives, originator branding still matters in the private market
Theyre imminently affordable, so Im hoping their NAD+ program lives up to their lofty reputation